Product Information
AJOVY 225 MG/1.5 ML AUTOINJECT is a brand product labeled by Teva Pharmaceuticals USA Inc., priced at $508.1707 per ML under NDC 51759020210. Its NADAC has been published 320 times since Aug 19, 2020.
Strength
225 mg/1.5mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
51759020210
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
FREMANEZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761089On Market Since
3/29/2020
Price Statistics
The NADAC for AJOVY 225 MG/1.5 ML AUTOINJECT has been published 320 times since Aug 19, 2020, and over the history we have for it it has risen 30.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $508.1707 per ML |
|---|---|
| All-time high | $508.3245 (Jul 15, 2026) |
| All-time low | $389.0033 (Aug 19, 2020) |
| 52-week high | $508.3245 |
| 52-week low | $483.7113 |
| Median price | $448.7802 |
| Average price | $451.4189 |
| Largest weekly change | +5.0% (Jan 7, 2026) |
| Weeks tracked | 320 |
| Tracking since | Aug 19, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fremanezumab-vfrm market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AJOVY 225 MG/1.5 ML AUTOINJECT?
The current National Average Drug Acquisition Cost (NADAC) for AJOVY 225 MG/1.5 ML AUTOINJECT, manufactured by Teva Pharmaceuticals USA Inc., is $508.1707 per ML (NDC 51759020210), effective Sep 30, 2026.
How has the price of AJOVY 225 MG/1.5 ML AUTOINJECT changed over time?
Over the history we have for it, the NADAC for AJOVY 225 MG/1.5 ML AUTOINJECT has risen 30.6%. It has been tracked across 320 weekly CMS publications since Aug 19, 2020.
What are the highest and lowest recorded NADAC prices for AJOVY 225 MG/1.5 ML AUTOINJECT?
Since Aug 19, 2020, the NADAC for AJOVY 225 MG/1.5 ML AUTOINJECT has ranged from a low of $389.0033 (Aug 19, 2020) to a high of $508.3245 (Jul 15, 2026), with a median of $448.7802 per ML.
Are there cheaper alternatives to AJOVY 225 MG/1.5 ML AUTOINJECT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK), is $507.4470 per ML — about 0% below AJOVY 225 MG/1.5 ML AUTOINJECT.
Who manufactures AJOVY 225 MG/1.5 ML AUTOINJECT?
AJOVY 225 MG/1.5 ML AUTOINJECT (NDC 51759020210) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a brand product.